Town Online 2022: 06: 08.16: 34
Pharmacists prepare ingredients to make a decoction of traditional Chinese medicine (TCM) at Yuzhou TCM Hospital in Yuzhou City, Henan Province, central China, January 13, 2022. Yuzhou of Henan Province implemented TCM for medically isolated individuals and frontline medical workers to help control the recent rise in infections COVID-19. (Xinhua/Li Jianan)
By Zheng Caixiong
Comoros President, Razali Assoumani, stated that his country has benefited in recent years from the use of treatment programs containing artemisinin to combat malaria.
El Othmani thanked the Chinese researchers for their foresight and generous assistance regarding the treatment. Its standards were released at the International Forum on the 50th Anniversary of the Discovery of Artemisinin and Building a Global Community of Health for All, held at the end of April.
With the help of China, Comoros has become one of the countries with the lowest malaria incidence in East Africa. From 2012 to 2020, the rate fell from 9 per 1,000 to less than 5 per 1,000 inhabitants.
The President stressed that “Comoros is also one of the countries that has succeeded in preventing the chain of transmission of local malaria.”
Since 2003, Guangdong Province has led six campaigns aimed at rapid elimination of malaria in Southeast Asia, Africa, and the South Pacific region. The results were fantastic.
“Guangdong, the hometown of the use of artemisinin to fight malaria, has sent more than 260 technicians abroad and helped train more than 10,000 local medical workers. Xu Qingfeng, deputy director of the Guangdong Provincial Health Commission, who also heads the regional office of traditional Chinese medicine, said,” The county has also established six outpatient malaria centers.”
Outpatient centers include the China and Africa Malaria Prevention and Treatment Center, the China and Comoros Center for Malaria Prevention and Treatment, the China and Papua New Guinea Center for Traditional Chinese Medicine, the China-Togo Center for Traditional Chinese Medicine, and the Malawi Chinese Center for Traditional Chinese Medicine. and the China-Malawi Artemisinin Research Center.
“These centers have played an important role in the fight against malaria worldwide,” Xu said at a recent press conference on malaria control with artemisinin in Guangzhou, the capital of Guangdong.
The Chinese official noted that with the help of Chinese doctors and artemisinin treatment, Cambodia is now listed as a country in the WHO-approved malaria elimination phase.
The national malaria incidence in Comoros has decreased by more than 98 percent, and zero malaria mortality has been achieved.
The first pilot region in Sao Tome and Principe reported no cases of malaria for the first time for eight consecutive months, while the incidence of malaria among 45,000 people in the Kirivina Islands, the pilot region of Papua New Guinea, decreased by more than 95 percent, and a rate of Zero deaths from malaria.
Xu also noted that official statistics show that since the implementation of artemisinin eradication projects, more than 20 million people in malaria-affected countries and regions around the world have directly benefited from the diagnosis and treatment of doctors and medical experts, and Guangdong’s use of artemisinin.
“Artemisinin, a drug that helped China eliminate malaria, is a gift of traditional Chinese medicine to the world, and Guangdong is not only the birthplace of the use of Artemisia annua, also known as sweet wormwood, the plant used to treat malaria patients, but also an industry leader around Artemisia annua becoming International “.
He reiterated that Guangdong has made remarkable achievements in promoting the cultivation of high-quality Artemisia annua varieties.
Due to extensive research and development, the content of artemisinin in wormwood from the province has increased from 0.5 percent to 2.97 percent.
Currently, an average of five kilograms of artemisinin can be extracted from a metric ton of Artemisia annua globally, although the figure is as high as 12 kilograms from a ton of Artemisia annua grown in Fengshun County of Meizhou, in eastern Guangdong.
“The fourth generation of artemisinin and piperaquine (ArtequickO) combination tablets, jointly developed and produced by Guangzhou University of Chinese Medicine and a domestic company, has obtained international patent protection in 40 countries, completed trademark registration in 36 countries and been listed and sold in 26 malaria-endemic country.
It is an innovative drug with completely independent intellectual property rights, which has many advantages, including high efficiency, quick effect, few side effects and simple application.
“The tablets have become the main free-market antimalarial drugs in countries with high malaria outbreaks, including Nigeria, Tanzania and Kenya,” he added.
Song Jianping, director of the Artemisinin Research Center of Guangzhou University of Chinese Medicine, said the WHO representative also initiated China’s contribution to the fight against malaria.
“The successful implementation of the artemisinin-based malaria elimination pilot project in the Sao Tome and Principe display area has opened a new path for that country to eliminate malaria,” he said.
Malaria is an infectious disease that threatens the health of all mankind. According to the World Health Organization’s 2021 Global Malaria Report, in 2020 more than 140 million cases of malaria were reported worldwide, with 470,000 deaths. These devastating findings indicate that malaria has become a major factor impeding social and economic development in the world, especially in Africa.
(Web Editor: 周, Zhao Jian)